Companies / Health Care / Health Care Services
Quest Diagnostics stock buybacks
DGX$552Mbought back in the 12 months to Jun 30, 2026 (from the statement of stockholders' equity)
Quest Diagnostics bought back $552M of its stock in the last twelve months, $464M more than it paid out in stock compensation. Its share count is down 0.9% from a year earlier.
Show as table
| Period | Value |
|---|---|
| Q3 '20 | $0 |
| Q4 '20 | $250M |
| Q1 '21 | $410M |
| Q2 '21 | $1.5B |
| Q3 '21 | $0 |
| Q4 '21 | $312M |
| Q1 '22 | $350M |
| Q2 '22 | $200M |
| Q3 '22 | $400M |
| Q4 '22 | $435M |
| Q1 '23 | $0 |
| Q2 '23 | $0 |
| Q3 '23 | $0 |
| Q4 '23 | $0 |
| Q1 '24 | $0 |
| Q2 '24 | $0 |
| Q3 '24 | $0 |
| Q4 '24 | $0 |
| Q1 '25 | $0 |
| Q2 '25 | $0 |
| Q3 '25 | $150M |
| Q4 '25 | $302M |
| Q1 '26 | $0 |
| Q2 '26 | $100M |
Show as table
| Period | Value |
|---|---|
| Q3 '20 | 137.0M |
| Q4 '20 | 136.0M |
| Q1 '21 | 135.0M |
| Q2 '21 | 127.0M |
| Q3 '21 | 125.0M |
| Q4 '21 | 125.0M |
| Q1 '22 | 121.0M |
| Q2 '22 | 119.0M |
| Q3 '22 | 118.0M |
| Q4 '22 | 114.0M |
| Q1 '23 | 113.0M |
| Q2 '23 | 114.0M |
| Q3 '23 | 114.0M |
| Q4 '23 | 111.0M |
| Q1 '24 | 112.0M |
| Q2 '24 | 112.0M |
| Q3 '24 | 113.0M |
| Q4 '24 | 115.0M |
| Q1 '25 | 113.0M |
| Q2 '25 | 113.0M |
| Q3 '25 | 113.0M |
| Q4 '25 | 113.0M |
| Q1 '26 | 112.0M |
| Q2 '26 | 112.0M |
$100Mlast quarter (Q2 2026)
$464Mnet of stock compensation ($88M)
−0.9%diluted shares, 1 year
−16.9%diluted shares, 5 years
$363Mdividends, 12 months
41%of free cash flow ($1.3B) spent on buybacks
$0raised by issuing stock, 12 months
$1.3Bleft under its authorization as of Jun 30, 2026
By fiscal year
Questions
- Does Quest Diagnostics buy back its stock?
- Quest Diagnostics bought back $552M of its stock in the last twelve months, $464M more than it paid out in stock compensation. Its share count is down 0.9% from a year earlier.
- How much did Quest Diagnostics spend on buybacks in fiscal 2025?
- $450M, according to its 10-K for the fiscal year ending Dec 31, 2025.
- Is Quest Diagnostics's share count going down?
- Its diluted share count changed −16.9% over five fiscal years and −0.9% over the last year.
- Does Quest Diagnostics have a buyback authorization?
- Its filings show $1.3B remaining under its repurchase authorization as of Jun 30, 2026.
Latest filing used: 10-Q for the period ending Jun 30, 2026, filed Jul 23, 2026 · open on SEC.gov